THPO and chronic myelogenous leukemia, BCR-ABL1 positive: CRKL has a role in platelet aggregation through inducing tyrosine phosphorylated via thrombopoietin in both chronic myeloid leukemia patients’ [39] and upregulated in myocardial infraction patients’ platelets [40].